Pharmaceutical composition comprising desloratadine
OwnerBalamurugan Jeganathan, Ganesh Gat +1inventors
InventorsBalamurugan Jeganathan, Ganesh Gat, Jawed Hussain
Life of this patent
Estimating the term…
Abstract
The present application relates to pharmaceutical compositions comprising desloratadine and a pharmaceutically acceptable polymer.
Claims24
A solid pharmaceutical composition comprising desloratadine or a pharmaceutically acceptable salt thereof as active ingredient, characterized in that the composition further comprises a pharmaceutically acceptable polymer, wherein the desloratadine or the pharmaceutically acceptable salt thereof and the pharmaceutically acceptable polymer are present in a molecular mixture.
A solid pharmaceutical composition comprising desloratadine or a pharmaceutically acceptable salt thereof as active ingredient, characterized in that the composition does not contain desloratadine or the pharmaceutically acceptable salt thereof which is in crystalline or amorphous form.
The process according to claim 20, wherein the dosage form is a tablet which is optionally further film coated.
A solid pharmaceutical composition comprising desloratadine or a pharmaceutically acceptable salt thereof as active ingredient, characterized in that the composition comprises a pharmaceutically acceptable polymer, copolymer, or block copolymer, further wherein said composition contains less than about 0.5 wt-% of N-formyl desloratadine, based on the total weight of the composition.
A solid pharmaceutical composition comprising desloratadine or a pharmaceutically acceptable salt thereof as active ingredient, characterized in that the composition comprises a pharmaceutically acceptable polymer, copolymer, or block copolymer, further wherein said composition contains less than about 1 wt-% of N-formyl desloratadine, based on the total weight of the composition, after a storage for 3 months at 40° C. and 75% relative humidity.
Dependencies are inferred from the claim text.